World women's chess champion, Hungarian-born Susan Polgar, is to join the scientific advisory board of Infectech (Sharon, PA), a biotechnology company developing rapid identification and typing tests for bacterial infections. Infectech's president, Mitchell Felder, believes that applying the same kind of thinking that underpins chess can help entrepreneurial companies make the right connections between seemingly disparate concepts in medical technology.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgson, J. Infectech's game plan. Nat Biotechnol 17, 735 (1999). https://doi.org/10.1038/11623
Issue Date:
DOI: https://doi.org/10.1038/11623